CL572, a potent agonist of Toll-like receptor 2/7, as a novel latency-reversing agent by A. Macedo, C.M. Assis, C.L. Novis, A. Spivak, V. Planelles, A. Bosque

Get full text

Direct and indirect effects of synthetic dual TLR-2 and TLR-7 agonists (Dual TLR-2/7) on latent HIV by A.B. Macedo, C.L. Novis, A.M. Spivak, V. Planelles, J. Szu-han Huang, Y. Ren, R. Brad Jones, A. Bosque

Get full text

Triazol-1-ol analogues as novel therapeutic leads towards reactivating and eradicating latent HIV-1 by manipulating SUMOylation of STAT5 by A. Bosque, A. Macedo, A. Spivak, C.L. Novis, L.J. Martins, M. Szaniawski, N.M. Archin, P.A. Luciw, D.M. Margolis, V. Planelles

Get full text